In an effort to boost drug discovery for the “toughest drug discovery problems” through the use of machine learning, precision medicines company Relay Therapeutics is acquiring Waltham, Mass.-based ZebiAI with an $85 million upfront payment.
Clinical-stage biopharmaceutical company Nabriva Therapeutics acquired Zavante Therapeutics, which is focused on developing novel therapies to improve the outcomes of hospitalized patients.
